Simon Tate - 09 Aug 2021 Form 3 Insider Report for Eliem Therapeutics, Inc. (CLYM)

Role
Director
Signature
/s/ Alan Hambelton, Attorney-in-Fact
Issuer symbol
CLYM
Transactions as of
09 Aug 2021
Net transactions value
$0
Form type
3
Filing time
09 Aug 2021, 18:18:44 UTC
Next filing
01 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ELYM No securities are beneficially owned. 0 09 Aug 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.